0000000000793470

AUTHOR

Stefanie Noeding

showing 1 related works from this author

Neo-/adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients …

2018

568Background: GAIN-2 compares the effectiveness and safety of a predefined idd regimen (EnPC) vs. a dd regimen with modification of single doses depending on individual hematological and non-hemat...

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtybusiness.industryNeo adjuvant03 medical and health sciencesRegimen030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinemedicinebusinessPathologicalComplete responseEarly breast cancerJournal of Clinical Oncology
researchProduct